摘要
Through structural optimization and ring fusion strategy, we designed a series of novel imidazo[1,2-a]pyrazine derivatives as potential tubulin inhibitors. These compounds displayed potent anti-proliferative activities (micromolar to nanomolar) against a panel of cancer cell lines (including HepG-2, HCT-116, A549 and MDA-MB-231 cells). Among them, compound TB-25 exhibited the strongest inhibitory effects against HCT-116 cells with an IC50 of 23 nM. Mechanism studies revealed that TB-25 could effectively inhibit tubulin polymerization in vitro, and destroy the dynamic equilibrium of microtubules in HCT-116 cells. In addition, TB-25 dose-dependently induced G2/M phase cell cycle arrest and apoptosis in HCT-116 cells. Furthermore, TB-25 suppressed HCT-116 cell migration in a concentration-dependent manner. Finally, molecular docking showed that TB-25 fitted well in the colchicine binding site of tubulin and overlapped nicely with CA-4. Collectively, these results suggest that TB-25 represents a promising tubulin inhibitor deserving further investigation.
学科与关键词
- Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidinesHuo, Xian-Sen; Jian, Xie-Er; Ou-Yang, Jie; Chen, Lin; Yang, Fang; Lv, Dong-Xin; You, Wen-Wei; Rao, Jin-Jun*; Zhao, Pei-Liang*European Journal of Medicinal Chemistry, 2021, 220: 113449.被引 39
- Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activitiesRen, Yichang; Ruan, Yong; Cheng, Binbin; Li, Ling; Liu, Jin; Fang, Yuyu; Chen, Jianjun*Bioorganic and Medicinal Chemistry, 2021, 46: 116376.被引 15
- Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activitiesKomuraiah, Buduma; Ren, Yichang; Xue, Mingming; Cheng, Binbin; Liu, Jin; Liu, Yao*; Chen, Jianjun*Chemical Biology and Drug Design, 2021, 97(5): 1109-1116.被引 5
